- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/08 - Drugs for disorders of the urinary system of the prostate
Patent holdings for IPC class A61P 13/08
Total number of patents in this class: 840
10-year publication summary
|
29
|
43
|
51
|
71
|
49
|
64
|
83
|
56
|
55
|
22
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1036 |
17 |
| Nymox Corporation | 37 |
16 |
| Takeda Pharmaceutical Company Limited | 2717 |
15 |
| Daiichi Sankyo Company, Limited | 1891 |
13 |
| ASKA Pharmaceutical Co., Ltd. | 100 |
10 |
| Xuanzhu Pharma Co., Ltd. | 52 |
10 |
| Janssen Pharmaceutica N.V. | 3217 |
9 |
| Kissei Pharmaceutical Co., Ltd. | 177 |
9 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 860 |
9 |
| Sunshine Lake Pharma Co., Ltd. | 618 |
9 |
| Shionogi & Co., Ltd. | 867 |
8 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
8 |
| The Regents of the University of California | 20594 |
7 |
| Sumitomo Chemical Company, Limited | 9012 |
7 |
| Nippon Shinyaku Co., Ltd. | 322 |
7 |
| Oncotherapy Science, Inc. | 244 |
7 |
| Dainippon Sumitomo Pharma Co., Ltd. | 173 |
6 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 184 |
6 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 691 |
6 |
| The Regents of the University of Michigan | 4928 |
5 |
| Other owners | 656 |